Generic placeholder image

Current Drug Targets - Infectious Disorders

Editor-in-Chief

ISSN (Print): 1568-0053
ISSN (Online): 1875-5852

1,3-beta-Glucan Synthase: A Useful Target for Antifungal Drugs

Author(s): J. Liu and M. K. Balasubramanian

Volume 1, Issue 2, 2001

Page: [159 - 169] Pages: 11

DOI: 10.2174/1568005014606107

Price: $65

Abstract

1,3-beta-glucan synthase, a multisubunit enzyme, is responsible for fungal cell wall construction, division septum deposition, and ascospore wall assembly. The catalytic subunit of this enzyme complex, an integral membrane protein, has been identified both in model yeasts Saccharomyces cerevisiae and Schizosaccharomyces pombe, and in pathogenic fungi such as Candida, Aspergillus, Cryptococcus and Pneumocystis species. The catalytic activity of the 1,3-beta-glucan synthase is regulated by a small GTPase of the Ras superfamily, the Rho-GTPase, and protein kinase C (Pkc)-like signaling molecules. It has been shown that the plasma membrane localization of this enzyme is essential for its activity. Interestingly, inhibition of 1,3-beta-glucan synthase activity by anti-fungal drugs of the lipopeptide type triggers a cell cycle feedback mechanism leading to cell cycle arrest. Recent progress in studies of molecular mechanisms of the temporal and spatial regulation of 1,3-beta-glucan synthase is presented. T he implication of the cell cycle checkpoint that is activated by the anti-fungal drugs is also discussed.

Keywords: Glucan Synthase, Saccharomyces cerevisiae, Schizosaccharomyces pombe, Cryptococcus and Pneumocystis, GTPase, guanosine 5-triphosphate (GTP), RHO, FKS homologous, ECHINOCANDIN-BINDING PROTEINS


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy